Sustainability LIVE to Spotlight Sustainable Supply Chains at London Climate Action Week

BE OPEN announces the awardees of the First, Second and Third Prizes in DESIGN EQUALITY with Innovation Competition in support of the UN...

Stellar Alpina Raises CHF 3.5M to Build Detonation-Based Propulsion for Mobility After Launch

Tillo and Paace Partner to Turn Everyday Movement Into Everyday Value

XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters

Willis: Leaders must move from caution to control as AI reshapes risk and resilience

Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy...

Futu Announces First Quarter 2026 Unaudited Financial Results

Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable

Safety, reliability and more sustainable options for fire, airport and civil rescue

Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation

ASPEED Technology and Lattice Semiconductor Announce Strategic Partnership to Advance Next-Generation Control for Datacenter Management

ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics

Huawei Named a Leader in the 2026 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure for the Fourth Year in a Row

LIFT Files NI 43-101 Technical Report on the Adina-Galinée Lithium Project, Quebec, Canada

Gabriela Marie Milton Honored as a Woman of the Month for May 2026 by P.O.W.E.R. (Professional Organization of Women of Excellence...

Two William Mattar Accident Lawyers Attorneys Admitted to Practice Before Supreme Court of the United States

Eternal Group Launches "The Eternal Path to China" at Esxence 2026, Offering a Strategic Roadmap for International Fragrance Brands Entering...

Imec and EV Group demonstrate wafer-to-wafer hybrid bonding with 200nm interconnect pitch and record high overlay accuracy

Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026